I
Immuneering Corp
NASDAQ:IMRX
Immuneering Corp
NASDAQ:IMRX
Price:
5.27
USD
7.99%
Market Cap:
$340.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Immuneering Corp
NASDAQ:IMRX
|
US |
|
M
|
MDX PCL
SET:MDX
|
TH |
|
R
|
Rane Engine Valve Ltd
NSE:RANEENGINE
|
IN |
|
C
|
Chaosua Foods Industry PCL
SET:CHAO
|
TH |
|
T
|
Tlou Energy Ltd
LSE:TLOU
|
AU |
|
Radana Bhaskara Finance Tbk PT
IDX:HDFA
|
ID |
|
S
|
Samart Telcoms PCL
SET:SAMTEL
|
TH |
|
L'Oreal SA
PAR:OR
|
FR |
|
Oversea-Chinese Banking Corporation Ltd
SGX:O39
|
SG |
|
P
|
Panoro Energy ASA
OSE:PEN
|
NO |
|
Appfolio Inc
NASDAQ:APPF
|
US |
|
Medexus Pharmaceuticals Inc
TSX:MDP
|
CA |
|
Perusahaan Perkebunan London Sumatra Indonesia Tbk PT
IDX:LSIP
|
ID |
|
Playtika Holding Corp
NASDAQ:PLTK
|
IL |
|
eBay Inc
NASDAQ:EBAY
|
US |
|
First Financial Northwest Inc
NASDAQ:FFNW
|
US |
|
Lufax Holding Ltd
NYSE:LU
|
CN |
|
China Automotive Systems Inc
NASDAQ:CAAS
|
CN |
Wall Street
Price Targets
IMRX Price Targets Summary
Immuneering Corp
Immuneering Corp
Wall Street analysts forecast IMRX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for IMRX is 17.34 USD with a low forecast of 11.11 USD and a high forecast of 31.5 USD.
Lowest
Price Target
11.11
USD
111% Upside
Average
Price Target
17.34
USD
229% Upside
Highest
Price Target
31.5
USD
498% Upside
Immuneering Corp Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IMRX's stock price target?
Price Target
17.34
USD
17.34
USD
According to Wall Street analysts, the average 1-year price target for IMRX is 17.34 USD with a low forecast of 11.11 USD and a high forecast of 31.5 USD.
